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Summary The syndecans, a family of cell-surface heparan sulphate proteoglycans, have been proposed to mediate cellular interactions with
extracellular effector molecules, such as growth factors and components of the extracellular matrix, during critical phases of development.
Transcripts of all four syndecans are expressed at varying levels in the developing rat intestine and in a series of immature rat intestinal
epithelial cell lines. In addition, we report the novel finding that, in the intestinal epithelial cell lines, expression of syndecan-1 transcript is
up-regulated by transformation with activated H-ras. This is in contrast to other cell lines in which ras transformation is associated with a
decrease in syndecan-1 levels. The observed increase in the syndecan-1 occurs as a result of increased transcription and can be correlated
with the degree of transformation of the IEC-18 cells. Transformation is also associated with a decrease in apparent molecular weight and
increased shedding of the proteoglycan into the culture medium. Increased shedding of syndecan-1 into the culture medium after
transformation with H-ras may contribute to the disruption of proteoglycan interactions with the extracellular matrix, leading to alterations in
cell adhesion and organization.
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In the rat intestine, dramatic changes over the last few days ofgesta-
tion result in the reorganization ofa tubular structure into the mature
crypt-villus structure in which the mesenchyme is lined by a simple
columnar epithelium (Moog, 1979; Trier and Moxey, 1979; Madara
et al, 1981). Underlying this morphogenesis and the maintenance of
the adultcrypt-villus structure are reciprocal interactions between the
epithelium and mesenchyme (Kedinger et al, 1986) that involve
recognition phenomena between cell-surface molecules and compo-
nents of the pericellular environment. Membrane-bound proteo-
glycans contribute to the regulation of cell behaviour through
interactions with extracellular matrix components or by acting as
co-receptors for biologically active peptides (Klagsbrun and Baird,
1991; Rapraeger et al, 1991; Yayon et al, 1991; Aviezeret al, 1994).
Two gene families encoding cell-surface heparan sulphate
proteoglycans (HSPG) have been identified on the basis of
sequence similarities between their core proteins: the glypican-
related integral membrane proteoglycans (PGs) and syndecan-like
integral membrane PGs (David,1993). We have reported that OCI-
5, a glypican-related HSPG (Filmus et al, 1995), is involved in
intestinal development (Filmus et al, 1988). Although syndecans-1
and -4 have been detected in the adult intestine (Kim et al, 1994),
the involvement of the syndecan family in intestinal development
or differentiation is largely unknown. The role of syndecan-1 in
epithelial-mesenchymal interactions during morphogenesis of a
variety of tissues raises the possibility of a similar role in the
developing intestine. The recent cloning of the four members of
the syndecan gene family (Carey et al, 1992; Kojima et al, 1992;
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Pierce et al, 1992) makes it feasible to analyse the expression of
this family in the intestine and in intestinal models. This work
describes the expression ofsyndecans in intestinal systems and the
effect of ras transformation on the expression of syndecan-1 in
intestinal epithelial cells (IECs).
MATERIALS AND METHODS
Materials
Rat intestinal epithelial cell (IEC) lines IEC-6, -14, -17, -18, -19
and -20 (Quaroni et al, 1979; Quaroni and Isselbacher, 1981) were
obtained from Dr A Quaroni (Cornell University); Rat2 fibro-
blasts, FR, fetal rat skin fibroblasts and NRK-52E from ATCC. Rat
syndecan-1 and syndecan-4 cDNA (Kojima et al, 1992) were
obtained from Dr Rosenberg (MIT) and rat syndecan-2 cDNA
(Pierce et al, 1992) was obtained from Dr Cowling (Christie
Hospital, Manchester, UK). Rat syndecan-3 cDNA (Carey et al,
1992) has been described. Sprague-Dawley rats were purchased
from Charles River. Enzymes were from ICN Chemicals. Serum
and Trizol reagent were from Gibco/BRL. Radioisotopes and
Renaissance chemiluminescence reagents were from NEN. All
other reagents were from Sigma Aldrich.
Cell culture
Cell lines were cultured in a humidified chamber at 37°C in 5%
carbon dioxide. IEC lines were grown in alpha minimal essential
medium (ax-MEM) supplemented with 3.6 mg ml-' glucose,
0.3 mg/ml-' glutamine, 0.27 U ml-' Humulin (Eli Lilly) and 5%
fetal bovine serum (Quaroni et al, 1979). Culture conditions for
ras-transformed IEC-18 cells have been described (Buick et al,
1987). FR, Rat2 and NRK-52E cells were grown in a-MEM
supplemented with 10% fetal bovine serum.
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Figure 1 Expression of syndecan-1, -2, -3 and -4 during intestinal
development. Northern blot analysis of syndecan-1, -2, -3 and -4 in 17- and
20-day embryos, 8-day suckling and 24-day post-natal rat intestine. Tubulin
probing was carried out to demonstrate equal loading
Northern blot analysis
RNA was prepared as described (Chomczynski and Sacchi, 1987)
from approximately 107 cells of each cell line or from samples of
the whole developing rat intestine. Poly-A+ RNA was prepared by
adsorption on cellulose-oligo-dT columns. Then, 3 gg of polyA+
RNA or 20 ,ug total RNA were separated by electrophoresis in
0.75% agarose-formaldehyde gels in phosphate buffer. The gel
was blotted onto Zeta-probe (Bio-Rad) and prehybridized (45%
formamide, 5 x Denhardt's, 2% sodium dodecyl sulphate (SDS),
5 x SSPE (Maniatis et al, 1989), and 100 gg/ml-' each of salmon
sperm DNA and polyA+ RNA) at 42°C for at least 1 h. For
hybridization, 5x105 c.p.m. ml-' 32P-labelled syndecan or tubulin
probe was boiled before addition to the buffer for a 16-h incuba-
tion at 42°C. Non-specifically bound probe was removed by
washing for 30 min in 2 x standard saline citrate (SSC), 0.2% SDS
at 420C, 30 min in 2 x SSC, 0.2% SDS at 65°C and 30 min in 1 x
SSC, 0.1% SDS at 65°C before exposing to Kodak X-Omat film at
-70°C with intensifying screens. Relative molecular mass was
determined relative to the 18S and 28S ribosomal RNA.
Probes
The 585-bp Kpnl-EcoRl fragment of pNWS127 was used as the
syndecan-1 probe (Kojima et al, 1992). It hybridizes to a major
band at 2.6 kb and a minor band at 3.4 kb, which may be obscured
Figure 2 Expression pattern of syndecans in IEC cell lines. Northern blot
analysis of syndecan-1, -2, -3 and -4 in IEC-6, -14, -17, -18, -19 and -20
cells. Tubulin probing was carried out to demonstrate equal loading
when syndecan- levels are high. The syndecan-2, probe which
recognizes mRNA of 3.4, 2.2 and 1.1 kb, was the 2-kb EcoRI
fragment ofthe pBS plasmid into which it was cloned (Pierce et al,
1992); syndecan-3 probe was the 2-kb EcoRl fragment from p1O4
and hybridizes to a 5.6-kb message (Carey et al, 1992); syndecan-
4 probe, which hybridizes to a 2.6-kb mRNA, was the 228-bp
XbaI-HindIII fragment from pNWS126 (Kojima et al, 1992). The
H-ras probe was the BamHI fragment of the c-H-ras oncogene
cloned from EJ bladder carcinoma cell line (Shih and Weinberg,
1982). Either tubulin (Elliott et al, 1985) or GAPDH (Fort et al,
1985) were used as control probes. For analysis of the transcrip-
tion rate, PUC18 was used as the negative control, while the 1.6-kb
Sacl fragment of L32 (Dudov and Perry, 1984) was used as the
positive standard. The DNA fragments were labelled with [32P]_
dCTP by random priming (Feinberg and Vogelstein, 1983; 1984).
Nuclear run-ons were carried out as described (Hu et al, 1995).
Preparation of PG-enriched extracts from conditioned
medium and cultured cells
Conditioned medium was harvested from confluent cultures ofIEC-
18 and its ras-transformed clones. After debris was removed by
low-speed centrifugation, the medium was supplemented with Tris-
buffered saline (TBS), 20 mM EDTA at pH 8, 5 mM phenylmethyl-
sulphonyl fluoride (PMSF) and mixed with DEAE-sephacel (5-ml
beads per liter ofmedium) overnight at4°C with gentle stirring. The
beads were recovered by low speed centrifugation, washed with
TBS plus 0.4 M sodium chloride and protease inhibitors (20 mM
EDTA, pH 8, 0.2 mm PMSF, 10 mm N-ethylmaleimide, 5 mM
benzamidine hydrochloride and 5 mm 6-aminohexanoic acid) and
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eluted with the same buffer containing 2 M sodium chloride. The
eluate was then concentrated on an Amicon Centriprep-50 at 4°C.
For cell extracts, confluent cells were harvested by scraping into
TBS, rinsed with TBS and 107 cells extracted in 100 gl of 1%
Triton-X 100 in 50 mm Tris, pH 7.4, and protease inhibitors (as
above) at 4°C for 30 min. Insoluble material was pelleted in a
microcentrifuge for 15 min at 14 000 r.p.m. and the supernatant
boiled for 10 min in SDS-PAGE loading buffer before gel
electrophoresis. Each sample represents material extracted from
5 x 106 cells.
Enzyme digestion of PG extracts
PG-enriched extracts were exchanged into TBS supplemented
with protease inhibitors, except EDTA. To each 50-,ul extract was
added 10 mU ofchondroitinase ABC for 1 h at 37°C. Fordigestion
with heparitinase, 20 mm calcium acetate and 1 mU ofheparitinase
were added for 1 h at 40°C.
Western blot analysis of PG extracts
PGs electrophoretically separated on polyacrylamide gels were
transferred overnight onto Immobilon (Millipore, Mississauga,
ON, Canada) inhalf-strength Towbin buffer (Towbin etal, 1979) at
250 mA at4'C. The blots wereblocked with 3% Carnation non-fat
milk, 0.05% Tween-20, in PBS for 30-60 min before incubating
with antibodies diluted in the same solution for 2 h at room
temperature or overnight at 4°C. After three washes with 0.05%
Tween-20 in PBS, the blots were incubated for 30-45 min with a
1:1000 dilution of horseradish-peroxidase-labelled goat anti-
rabbit secondary antibodies in blocking solution. The blots were
washed three to five times with large volumes of0.05% Tween-20
in PBS and incubated with Renaissance enhanced chemilumines-
cence solutions before exposure to radiographic film.
RESULTS
Transcript levels in developing rat intestine and
intestinal epithelial cells
To investigate the potential role of the syndecan gene family in
intestinal cell behaviour, we first analysed the levels of syndecan
transcripts in whole fetal and adult rat intestine. Northern blot
analysis (Figure 1) shows that transcripts ofall four syndecans are
expressed in the intestine but the levels of syndecans-2, -3 and-4
are higher during fetal development and through the suckling
period than in the mature intestine (24 days post natal). Syndecans-
2, -3 and-4 were barely detectable in the adult intestine, while
syndecan-1 was expressed in both fetal and adult intestine.
We then analysed the levels of syndecan transcripts in IEC, a
series of immortalized rat intestinal epithelial cells that have been
widely used as models of developing intestinal crypt cells.
Northern blot analysis (Figure 2) shows that transcripts of all four
syndecans were widely expressed but at varying levels in the six
IEC lines. The sizes ofindividual transcripts detected were consis-
tent with those previously published. The 2.6-kb syndecan-l tran-
script was present at roughly equivalent levels in all cell lines.
Smaller amounts of the minor 3.4-kb transcript were also
observed. The 3.4-, 2.2-, and 1.1-kb syndecan-2 transcripts
showed a wide range of expression, being detected at very high
levels in IEC-14, at slightly lower levels in IEC-18, -19, and -20,
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Figure 3 Expression of syndecan-1 transcripts in IEC-18 cells before and
aftertransformation with activated H-ras. Northern blot analysis of syndecan-
1 expression in ras-transformed IEC-18 clones arranged in increasing order
of ras and corresponding increase in malignant phenotype. The Northern blot
was also probed with GAPDH to demonstrate equal loading and with H-ras to
facilitate correlation of levels of expression of H-ras and syndecan-1
transcripts
and at low levels in IEC-6 and -17. In contrast, the 5.6-kb
syndecan-3 transcript was expressed at high levels in only IEC-6
cells. High levels ofthe 2.6-kb syndecan-4 transcript were detected
in IEC-6, -18 and -19 with moderate levels present in IEC-14, -17
and -20. Each of the cell lines had a distinct complement of tran-
scripts of the four syndecans. As with expression in the intestine,
there was no obvious pattern associating high levels of one
syndecan with another or mutual exclusion of any of the other
syndecan transcripts.
Effect of malignant transformation on transcript levels
of syndecan-1
Our laboratory has developed a model ofmalignanttransformation
of intestinal cells based on the expression of activated human H-
ras in IECs (Buick et al, 1987). These transformed cells show
altered expression of several cell-surface molecules involved in
cell-cell or cell-matrix interactions. These include the down-regu-
lation of OCI-5 (Filmus et al, 1988), a member of the glypican
family ofintegral membrane PGs (David, 1993), andup-regulation
of CD44 (Jamal et al, 1994). Syndecan-1 has been reported to
function as an adhesion receptor for extracellular matrix in epithe-
lial cells. Syndecan-1 transcripts were expressed by all the IEC
lines examined. We further investigated the effect of malignant
transformation on syndecan-1 expression using three ras-trans-
formed cell lines derived from IEC-18, i.e. IEC-ras-3, IEC-ras-4
and IEC-ras-7. The relative levels of ras protein expression in
these cell lines correspond to the degree of malignant transforma-
tion (Buick et al, 1987). The IECs changed from cuboidal to
fusiform morphology after ras transformation and produced
rapidly growing tumours in syngeneic rats or nude mice. As shown
in Figure 3, the level of syndecan-1 transcript accumulation
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et al, 1992; Yeaman and Rapraeger, 1993) and post-translational
levels (Sanderson and Bermfield, 1988; Bemfield and Sanderson,
1990; Inki et al, 1992; Kirjavainen et al, 1993). Nuclear run-on
experiments (Figure 5) show that ras transformation of IEC-18
cells resulted in a 9.6-fold increase in the transcription rate, similar
to the increase in syndecan-1 transcripts shown by Northern blot
analysis. Therefore, syndecan-1 is regulated at the transcriptional
level in ras-transformed IEC-18 cells.
GAPDH
Figure 4 Northern blot analysis of dexamethasone induced ras
transformation. Clone 25 (IEC-18 transfected with H-ras under the control of
MMTV promoter) cells were induced with 1 gM dexamethasone for the times
(h) indicated. GAPDH probing was carried out to demonstrate equal loading
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Figure 5 Regulation of syndecan-1 expression in IEC-18 cells before and
after H-ras transformation. Nuclear run-ons were used to determine the effect
of ras transformation on transcriptional rate. The ratio of signals in non-
transformed compared with transformed was normalized to L32
increases in tandem with increasing levels of ras expression.
Transcript levels ofthe other syndecans did not change as dramat-
ically as syndecan- 1 upon transformation ofIEC-18 with ras (data
not shown). The effect of ras expression on syndecan-1 transcript
accumulation was also confirmed in a clone transfected with H-ras
under the control of the MMTV promoter. Figure 4 shows that
syndecan- 1 transcript levels increased when ras expression was
induced with dexamethasone for 12 h, an increase still evident
after 48 h. This increase in syndecan- 1 transcripts after ras trans-
formation is a novel finding: previous reports have indicated that
ras transformation of colonic (Levy et al, 1996) or mammary
epithelial cells (Kirjavainen et al, 1993) results in decreased
membrane-anchored syndecan-1 but unaltered transcript levels
(see Discussion).
Effect of rastransformation on transcriptional rate of
syndecan-1
Syndecan-1 levels have been reported to be regulated at the
transcriptional, post-transcriptional (Sanderson et al, 1992; Vainio
Effect of malignant transformation on syndecan-1
The relationship of elevated syndecan-1 transcript in ras-trans-
formed cells to PG expression was analysed using an antiserum
specific for the syndecan-1 ectodomain (Carey et al, 1994). The
Western blot in Figure 6 showed that the transcriptional up-regula-
tion ofsyndecan-1 by transformation with ras was associated with
an increase in the corresponding protein. The antiserum used
recognized the intact syndecan- 1 as a high Mr smear characteristic
of proteoglycans (Figure 6). In contrast, a sharper and lower Mr
band was seen after chondroitinase ABC and heparitinase diges-
tion of syndecan-1 GAG chains (see Figure 7). While very little
syndecan- 1 was present in either the IEC-18-conditioned medium
(Figure 6A) or cell lysate (Figure 6B), the level of syndecan-1
increased in the transformed cell lines. The distribution of
syndecan- 1 was also altered in relationship to levels of ras expres-
sion. In IEC-ras-3, the least transformed clone used (Buick et al,
1987), the increase in syndecan-1 expression was at the cell
surface with little shed into the medium. In contrast, a greater
proportion of syndecan-1 was shed into the growth medium, with
little resident on the cell surface ofthe highly transformed IEC-ras
7. In IEC-ras-4 cells, which had intermediate ras levels, syndecan-
1 of intermediate Mr was evident both at the cell surface and in
conditioned medium. Moreover, cells expressing higher levels of
ras expressed syndecan- 1 of a lower apparent Mr: the apparent Mr
of syndecan-1 was over 200 kDa for IEC-18 and IEC-ras-3,
approximately 200 kDa for IEC-ras-4 and less than 200 kDa for
IEC-ras-7. The immunoreactive species in the medium was
smaller than that in the cell extracts, especially in IEC-ras-7 cells.
An increased Mr of syndecan-1 has previously been reported for
both ras-transformed mouse keratinocytes (Inki et al, 1992) and
mouse mammary (NOG) cells (Kirjavainen et al, 1993), accompa-
nied by a decreased amount ofPG.
GAG chain substitution of syndecan-1
Syndecan- 1 is generally expressed as a hybrid PG bearing both CS
and HS chains (Rapraeger et al, 1985). To analyse the syndecan-
GAG chain substitutions, conditioned medium from IEC-ras-7
cells was digested with heparitinase, chondroitinase ABC or a
combination of both. The Western blot in Figure 7 shows that the
Mr of syndecan- 1 isolated from the culture medium of IEC-ras 7
cells decreased slightly after digestion with heparitinase but
decreased more when a combination of chondroitinase and
heparitinase was used. As chondroitinase alone did not result in
detectable reduction in size of the syndecan-1, HS digestion may
be required to expose the CS chains to degradation. These data
indicate that the core protein is substituted with both HS and CS as
in other cells. Thus, the lower Mr syndecan-1 expressed by the
more highly ras-transformed IEC-18 cells does not appear to be a
result ofthe loss of a specific type ofGAG chain but may be due to
an overall decrease in the length or number ofchains.
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Figure 6 Detection of syndecan-1 in transformed IEC-18 cell lysates and conditioned medium. Western blot analysis of syndecan-1 from the conditioned
medium (A) and cell surface (B) of IEC-18 cells and the three ras-transformed IEC-18 clones using an antiserum specific for the syndecan-1 ectodomain
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Figure 7 Enzyme susceptibility of syndecan-1 shed into the medium by
IEC-ras-7 cells. Conditioned medium from IEC-ras-7 cells was digested with
chondroitinase ABC, heparitinase or both before Western blotting using the
syndecan ectodomain-specific antibody
DISCUSSION
Expression of the four members of the syndecan family is regu-
lated in diverse tissues at critical periods ofdevelopment or remod-
elling (Elenius et al, 1991; Bemfield et al, 1992; Kim et al, 1994).
To assess the potential contribution of the syndecan family to the
complex epithelial-mesenchymal interactions during morphogen-
esis of the intestine, we analysed the expression of syndecan gene
family members in intestinal models. In the whole rat intestine,
transcripts of all four syndecans were detected during develop-
ment. While syndecan- transcripts were expressed both during
development and in the mature intestine, syndecan-2 and
syndecan-3 transcripts were expressed at significantly higher
levels during a period of morphogenetic change in the intestine,
spanning day 17 of embryogenesis to 8 days post natal, and were
subsequently down-regulated to barely detectable levels in the
adult intestine. Syndecan-4 transcripts were up-regulated in the 8-
day suckling intestine and then down-regulated in the mature intes-
tine. The pattern ofexpression ofthe gene family in intestinal cells
was complex, most likely reflecting differences in regulation of
their expression. Each of the IEC lines analysed had a unique
pattern of syndecan transcript expression, indicative ofdifferences
in the state of cellular differentiation and interactions with other
cells and the extracellular matrix. The expression ofeach syndecan
was independent of the others, with no apparent association or
mutual exclusion. This contrasts with the complementary expres-
sion of syndecan- and syndecan-3 transcripts in the developing
rat central nervous system (Carey et al, 1992), and with the co-
ordinated expression of syndecan- and syndecan-2 in the devel-
oping lung mesenchyme (Bemfield et al, 1992; David et al, 1992;
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Kim et al, 1994). While the function of the syndecans during
morphogenesis in the intestine is unknown, their expression and
differential regulation is compatible with the notion that different
combinations of the molecules are required at different stages.
Although basement membrane HSPGs of the developing intestine
are produced exclusively by the epithelial cells (Simon-Assmann
et al, 1989), the cellular origin of syndecans is not clear. Their
expression in IEC lines is consistent with their expression by the
epithelium but expression by the mesenchyme and plasma cells,
concurrently or at different stages, cannot be excluded.
Application of in situ approaches will resolve this issue. Several
syndecans may be involved during morphogenesis ofthe intestine,
with the possible exception of syndecan-3, whose expression
remains constant during embryogenesis and between IEC lines.
Our current investigation has focused on the expression and
regulation of syndecan-1 in intestinal models.
We report the novel finding that transformation of IEC-18 cells
with H-ras resulted in a dramatic increase in the transcript levels of
syndecan-1. In the series of increasingly malignant IEC-ras-3,-4
and -7 cells, the up-regulation of syndecan-1 increased in tandem
with the level ofexpression ofras transcripts. Similar up-regulation
of syndecan-1 transcripts upon ras transformation was observed in
all IEC lines analysed and in FR cells but not in Rat2 fibroblasts or
NRK-52E. This contrasts with the reported down-regulation of
syndecan-1 transcripts in the human colonic carcinoma cell line
Caco-2 after transformation with ras or PyMT (Levy et al, 1996).
However, it is difficult to compare these results directly because the
cell lines used represent different physiological situations: IEC-18
are non-tumorigenic cells, derived from normal epithelium, while
Caco-2 were already malignant before transformation with ras. In
addition, these conflicting results may reflect the multiple levels of
regulation of syndecan-1 expression, including transcriptional
control, post-transcriptionally and translationally or post-
translationally. We determined that increased syndecan-1 transcript
levels in H-ras transformed IEC-18 cells result from an increased
transcription rate. Concomitant changes in Mr and shedding of the
molecule from the cell surface shows that the molecule is regulated
at multiple levels. In contrast, in both ras-transformed NOG
(Kirjavainen et al, 1993), and Caco-2 cells (Levy et al, 1996), there
is a net decrease in the amount ofmembrane-anchored syndecan-1
but no alteration in mRNA levels. The up-regulation ofsyndecan-1
transcripts upon ras transformation of intestinal epithelial (IEC)
and skin fibroblast (FR) cells but not of embryonic fibroblasts
(Rat2) or epithelial-like kidney cells (NRK-52E) provides further
evidence that the level ofregulation ofsyndecan-1 is cell and tissue
type specific.
In addition to changes in PG levels, the Mr of syndecan-1 is
altered in various transformed cell lines. The decrease in size of
syndecan-1 in ras-transformed IEC-18 cells is consistent with the
smaller syndecan-1 ectodomain expressed by ras-transformed
Caco-2 cells (Levy et al, 1996) but contrasts with the increased Mr
due to altered glycosylation in transformed keratinocytes (Inki et
al, 1992). Ras transformation of IEC-18 cells also results in
increased shedding of syndecan-1 from the cell surface, similar to
the effect oftransformation in keratinocytes (Inki et al, 1992). This
may be related to the acquisition of a less flattened morphology
(Buick et al, 1987), consistent with previous reports ofshedding of
the syndecan-1 ectodomain upon cell rounding (Jalkanen et al,
1987). GAG chain substitution is an important component in
syndecan-1 function. Generally, syndecans bear both CS and HS
GAG chains. While CS chains are thought to be involved in
detachability of cells and thus tumour metastasis, HS chains are
associated with increased adhesion to extracellular matrix (Culp et
al, 1978). However, HS levels are elevated in certain mammary
carcinoma (Mangakis et al, 1990) and in a highly metastatic
human melanoma cell line (Timar et al, 1992). Although
enzymatic digestion of syndecan-1 isolated from IEC-ras-7 cells
showed substitution with both CS and HS chains, alterations in
both the size and subcellular localization of the molecules may
affect their interactions with other molecules in the cellular
microenvironment. Further experiments to determine the changes
in structure and activity of the GAG chains and expression of
cellular endoglycosidases will detect the more subtle effects of ras
transformation that may affect cell shape and adhesion, and
contribute to the malignant phenotype. It is important to note that
the behaviour of cell lines in vivo does not necessarily mirror in
vitro tests that gauge the transformed phenotype. A recent study of
syndecan-1-transfected 293T (human embryonic kidney epithe-
lial) cells found that, although the transformed cells grew better in
reduced serum and showed reduced motility, these cells were
tumorigenic when injected into nude mice (Numa et al, 1995).
Ras-transformed IEC-18 cells are tumorigenic in nude mice
(Buick et al, 1987), while the parent cells are not.
In summary, we have analysed syndecan expression in intestinal
cells and tissues. The syndecans were expressed at varying levels
in IEC lines and in the developing intestine, leading us to speculate
that they play specific roles at discrete developmental stages. We
report the novel finding that ras transformation of IEC-18 cells
resulted in up-regulation of syndecan-1 but not syndecans-2, -3 or
-4. This appears to be the result of an increased transcriptional
rate. In addition, syndecan-1 expressed by ras transformants
showed decreased Mr and increased shedding into the medium.
The concurrent expression and differential regulation ofsyndecans
in both normal and transformed phenotypes are indicative of a
complexity that will have to be addressed in determining the role
of any one component in differentiation and development of the
intestine. Experiments aimed at understanding the functional
significance of syndecan-1 expression in relation to ras transfor-
mation may provide further information on processes involved in
malignant transformation.
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